BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Trotti LM, Karroum EG. Melatonin for Sleep Disorders in Patients with Neurodegenerative Diseases. Curr Neurol Neurosci Rep 2016;16:63. [PMID: 27180068 DOI: 10.1007/s11910-016-0664-3] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Kim GH, Kim Y, Yoon S, Kim SJ, Yi SS. Sleep-inducing effect of Passiflora incarnata L. extract by single and repeated oral administration in rodent animals. Food Sci Nutr 2020;8:557-66. [PMID: 31993179 DOI: 10.1002/fsn3.1341] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
2 Ishizaki A, Uemura A, Kataoka H. A sensitive method to determine melatonin in saliva by automated online in-tube solid-phase microextraction coupled with stable isotope-dilution liquid chromatography-tandem mass spectrometry. Anal Methods 2017;9:3134-40. [DOI: 10.1039/c7ay00622e] [Cited by in Crossref: 17] [Article Influence: 3.4] [Reference Citation Analysis]
3 Cox C, Mackett A. Melatonin as first‐line treatment for sleep disorders in Parkinson's disease? Prog Neurol Psychiatry 2021;25:29-32. [DOI: 10.1002/pnp.728] [Reference Citation Analysis]
4 Jiki Z, Lecour S, Nduhirabandi F. Cardiovascular Benefits of Dietary Melatonin: A Myth or a Reality? Front Physiol 2018;9:528. [PMID: 29867569 DOI: 10.3389/fphys.2018.00528] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 8.8] [Reference Citation Analysis]
5 Nikles J, O'Sullivan JD, Mitchell GK, Smith SS, McGree JM, Senior H, Dissanyaka N, Ritchie A. Protocol: Using N-of-1 tests to identify responders to melatonin for sleep disturbance in Parkinson's disease. Contemp Clin Trials Commun 2019;15:100397. [PMID: 31338478 DOI: 10.1016/j.conctc.2019.100397] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
6 Wu HJ, Wu C, Niu HJ, Wang K, Mo LJ, Shao AW, Dixon BJ, Zhang JM, Yang SX, Wang YR. Neuroprotective Mechanisms of Melatonin in Hemorrhagic Stroke. Cell Mol Neurobiol 2017;37:1173-85. [PMID: 28132129 DOI: 10.1007/s10571-017-0461-9] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 4.2] [Reference Citation Analysis]
7 Kim GH, Lim K, Yang HS, Lee JK, Kim Y, Park SK, Kim SH, Park S, Kim TH, Moon JS, Hwang IK, Yoon YS, Seo HS, Nam SM, Kim MY, Yoon SG, Seong JK, Yi SS. Improvement in neurogenesis and memory function by administration of Passiflora incarnata L. extract applied to sleep disorder in rodent models. J Chem Neuroanat 2019;98:27-40. [PMID: 30951822 DOI: 10.1016/j.jchemneu.2019.03.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
8 Wennberg AMV, Wu MN, Rosenberg PB, Spira AP. Sleep Disturbance, Cognitive Decline, and Dementia: A Review. Semin Neurol 2017;37:395-406. [PMID: 28837986 DOI: 10.1055/s-0037-1604351] [Cited by in Crossref: 59] [Cited by in F6Publishing: 50] [Article Influence: 11.8] [Reference Citation Analysis]
9 Shen Y, Guo X, Han C, Wan F, Ma K, Guo S, Wang L, Xia Y, Liu L, Lin Z, Huang J, Xiong N, Wang T. The implication of neuronimmunoendocrine (NIE) modulatory network in the pathophysiologic process of Parkinson's disease. Cell Mol Life Sci 2017;74:3741-68. [PMID: 28623510 DOI: 10.1007/s00018-017-2549-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
10 Li L, Zhao Z, Ma J, Zheng J, Huang S, Hu S, Gu Q, Chen S. Elevated Plasma Melatonin Levels Are Correlated With the Non-motor Symptoms in Parkinson's Disease: A Cross-Sectional Study. Front Neurosci. 2020;14:505. [PMID: 32508583 DOI: 10.3389/fnins.2020.00505] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
11 Vecchierini MF, Kilic-Huck U, Quera-Salva MA; Members of the MEL consensus group of the SFRMS. Melatonin (MEL) and its use in neurological diseases and insomnia: Recommendations of the French Medical and Research Sleep Society (SFRMS). Rev Neurol (Paris) 2021;177:245-59. [PMID: 32921425 DOI: 10.1016/j.neurol.2020.06.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
12 Mayer G, Happe S, Evers S, Hermann W, Jansen S, Kallweit U, Muntean ML, Pöhlau D, Riemann D, Saletu M, Schichl M, Schmitt WJ, Sixel-Döring F, Young P. Insomnia in neurological diseases. Neurol Res Pract 2021;3:15. [PMID: 33691803 DOI: 10.1186/s42466-021-00106-3] [Reference Citation Analysis]
13 Phillipson OT. Alpha-synuclein, epigenetics, mitochondria, metabolism, calcium traffic, & circadian dysfunction in Parkinson's disease. An integrated strategy for management. Ageing Res Rev 2017;40:149-67. [PMID: 28986235 DOI: 10.1016/j.arr.2017.09.006] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 6.8] [Reference Citation Analysis]
14 Mischoulon D. Popular Herbal and Natural Remedies Used in Psychiatry. Focus (Am Psychiatr Publ) 2018;16:2-11. [PMID: 31975894 DOI: 10.1176/appi.focus.20170041] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
15 Dhingra A, Janjua AU, Hack L, Waserstein G, Palanci J, Hermida AP. Exploring Nonmotor Neuropsychiatric Manifestations of Parkinson Disease in a Comprehensive Care Setting. J Geriatr Psychiatry Neurol 2021;34:181-95. [PMID: 32242493 DOI: 10.1177/0891988720915525] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
16 Hossain MF, Wang N, Chen R, Li S, Roy J, Uddin MG, Li Z, Lim LW, Song YQ. Exploring the multifunctional role of melatonin in regulating autophagy and sleep to mitigate Alzheimer's disease neuropathology. Ageing Res Rev 2021;67:101304. [PMID: 33610813 DOI: 10.1016/j.arr.2021.101304] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 13.0] [Reference Citation Analysis]